Atticus Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.7K | Buy |
143
+3
| +2% | +$1.34K | 0.02% | 290 |
|
|
2025
Q1 | $67.9K | Hold |
140
| – | – | 0.02% | 200 |
|
|
2024
Q4 | $56.4K | Buy |
140
+125
| +833% | +$50.3K | 0.02% | 233 |
|
|
2024
Q3 | $6.98K | Sell |
15
-4
| -21% | -$1.86K | ﹤0.01% | 413 |
|
|
2024
Q2 | $8.91K | Hold |
19
| – | – | ﹤0.01% | 394 |
|
|
2024
Q1 | $7.94K | Hold |
19
| – | – | ﹤0.01% | 420 |
|
|
2023
Q4 | $7.73K | Hold |
19
| – | – | ﹤0.01% | 424 |
|
|
2023
Q3 | $6.61K | Hold |
19
| – | – | ﹤0.01% | 440 |
|
|
2023
Q2 | $6.69K | Hold |
19
| – | – | ﹤0.01% | 427 |
|
|
2023
Q1 | $5.99K | Buy |
19
+15
| +375% | +$4.73K | ﹤0.01% | 424 |
|
|
2022
Q4 | $1.16K | Sell |
4
-20
| -83% | -$5.78K | ﹤0.01% | 484 |
|
|
2022
Q3 | $7K | Hold |
24
| – | – | ﹤0.01% | 409 |
|
|
2022
Q2 | $7K | Buy |
24
+7
| +41% | +$2.04K | ﹤0.01% | 440 |
|
|
2022
Q1 | $4K | Buy |
+17
| New | +$4K | ﹤0.01% | 484 |
|
|
2021
Q3 | – | Sell |
-347
| Closed | -$70K | – | 457 |
|
|
2021
Q2 | $70K | Sell |
347
-1,380
| -80% | -$278K | 0.03% | 199 |
|
|
2021
Q1 | $371K | Buy |
1,727
+897
| +108% | +$193K | 0.18% | 76 |
|
|
2020
Q4 | $196K | Buy |
830
+415
| +100% | +$98K | 0.1% | 98 |
|
|
2020
Q3 | $113K | Buy |
415
+410
| +8,200% | +$112K | 0.07% | 128 |
|
|
2020
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 291 |
|
|
2020
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 296 |
|
|
2019
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 370 |
|